NASDAQ: OPCH · Medical Care Facilities
Option Care Health (OPCH) fair value and price range
As of 28 Sep 2026, Faircurve's model values Option Care Health (OPCH) at $25.11 a share. The stock last closed at $22.64, which puts the model's fair value 10.9% above the price. The model grades the evidence behind this valuation as low, so no verdict is shown. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It does not say how likely the fair value is to be right.
Revalued . Price is the close of 2 Oct 2026. Option Care Health, Inc.
Faircurve Insights · 28 Sep 2026
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States.
On 28 Sep 2026, Faircurve's model gave a fair value of $25.11 a share, the midpoint of 2,000 simulations. This was a -5.9% move from the $26.68 given by the previous run on 19 Sep 2026. The calibrated range over 63 trading days was $21.07 to $30.62, built from the fair value, since there was no live options data for the stock, calibrated weekly against realised prices (4,327 past valuations, refreshed 26 Sep 2026). Ranges built this way held the price 60% of the time at this horizon. The model graded the evidence behind this valuation as low.
The overall quality score was 63 out of 100 against comparable companies. The model compared it with National HealthCare Corporation (NHC), Concentra Group Holdings Parent, Inc. (CON), Addus HomeCare Corporation (ADUS), Hims & Hers Health, Inc. (HIMS), and Astrana Health, Inc. (ASTH). Moves around the last 8 earnings reports, measured from the close before each report to the close after it, included -0.1% on 29 Jul 2026 and -25.5% on 30 Apr 2026, with a median size, ignoring direction, of 7.2%.
Written from the figures on this page for the 28 Sep 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
What price range does the model give OPCH?
The calibrated range for OPCH over 63 trading days is $21.07 to $30.62. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 4,327 past valuations, refreshed 26 Sep 2026). Ranges built this way held the price 60% of the time at this horizon.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $17.69 to $34.56. In 58% of the simulations the fair value came out above the price the model ran on.
How does OPCH score on business quality?
Option Care Health's overall quality score is 63 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 40 | 10.6%ROIC | 31.3% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 95 | 1.65xFCF / net income | 0.51x |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analyst estimate revisions. | 41 | 13.0%Revenue growth, trailing | 19.6% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 100 | 9.5%Net buybacks / market value | 1.1% |
| Balance sheetNet debt to EBITDA and interest coverage. | 38 | 2.59xNet debt / EBITDA | -0.04x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 100 | 0.7 ptsEBITDA margin downside volatility, 5y | 12.4 pts |
How does OPCH compare with similar companies?
The companies in medical care facilities closest to Option Care Health in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| NHC National HealthCare Corporation | $227.66 | $263.84 | +15.9% | Undervalued |
| CON Concentra Group Holdings Parent, Inc. | $35.65 | $38.11 | +6.9% | Fairly valued |
| ACHC Acadia Healthcare Company, Inc. | $28.06 | $34.20 | +21.9% | Low evidence grade |
| MD Pediatrix Medical Group, Inc. | $25.97 | $30.52 | +17.5% | Low evidence grade |
| ADUS Addus HomeCare Corporation | $111.27 | $126.76 | +13.9% | Fairly valued |
| HIMS Hims & Hers Health, Inc. | $29.00 | $29.24 | +0.8% | Fairly valued |
| ASTH Astrana Health, Inc. | $35.88 | $38.17 | +6.4% | Fairly valued |
| CHE Chemed Corporation | $507.50 | $507.32 | 0.0% | Low evidence grade |
All medical care facilities stocks ranked by gap to fair value
When does OPCH report earnings, and how has the stock reacted?
Option Care Health's next earnings report is scheduled for 29 Oct 2026. Companies can move their dates.
Options prices on 2 Oct 2026 imply a move of about 16.9% in either direction through the nearest expiry, about 48 days out, a window that includes the report. That is the size the market is pricing, not a direction.
How OPCH moved around its last 8 earnings reports
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across these 8 reports, ignoring direction, was 7.2%.
| Report date | Two session move |
|---|---|
| 29 Jul 2026 | -0.1% |
| 30 Apr 2026 | -25.5% |
| 24 Feb 2026 | -6.9% |
| 30 Oct 2025 | -9.2% |
| 30 Jul 2025 | -2.6% |
| 29 Apr 2025 | -7.5% |
| 26 Feb 2025 | +1.7% |
| 30 Oct 2024 | -24.5% |
Option Care Health at a glance
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States.
- Market value
- $3.5B
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Revenue expected, next twelve months
- $6.0B
- Consensus revenue growth, next fiscal year
- +1.8%
- Analysts with estimates
- 8
- Beta to the US market
- -0.09
- First valued by Faircurve
- 11 Jul 2026
How the fair value is worked out: the model prices Option Care Health on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 19 Sep 2026 the model's fair value for OPCH was $26.68. As of 28 Sep 2026 it is $25.11, a change of -5.9%. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Option Care Health's valuation
Is Option Care Health stock undervalued or overvalued?
Faircurve's model puts OPCH's fair value at $25.11 a share against a last close of $22.64, as of 28 Sep 2026. The model grades the evidence behind this valuation as low, so no verdict is shown. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It does not say how likely the fair value is to be right.
What is OPCH's fair value?
$25.11 a share as of 28 Sep 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $17.69 to $34.56.
What price range does the model give OPCH?
$21.07 to $30.62 over 63 trading days. Ranges built this way held the price 60% of the time across 4,327 past valuations, refreshed 26 Sep 2026.
When does Option Care Health report earnings next?
The next report is scheduled for 29 Oct 2026. Companies can move their dates.
How much has OPCH moved on past earnings reports?
Across its last 8 reports the median two session move was 7.2%, ignoring direction. The largest was -25.5% around the report of 30 Apr 2026.
How confident is the model in this valuation?
The model's evidence grade for OPCH is low. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.